MEDICINOVA, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $802.6K | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $5.3M | $3.9M | $3.1M | $2.7M | $2.9M | $2.7M | $4.5M | $7.8M |
| SG&A Expense | $10.0M | $8.8M | $7.4M | $5.8M | $6.0M | $6.7M | $6.7M | $8.3M |
| Operating Income | $-15.6M | $-13.0M | $-10.9M | $-8.8M | $-9.2M | $-4.0M | $-10.9M | $-16.1M |
| Operating Margin | — | — | — | — | — | — | -1,363.8% | — |
| Interest Expense | — | $298 | $454 | $514 | $628 | — | — | $1.6M |
| Pretax Income | $-14.7M | $-12.9M | $-10.9M | $-8.8M | $-9.2M | $-4.0M | $-11.0M | $-17.7M |
| Income Tax Expense | $5.3K | $-1.7M | $3.8K | $7.4K | $-4.0K | $4.0K | $11.1K | $11.6K |
| Net Income | $-14.7M | $-11.2M | $-10.9M | $-8.8M | $-9.2M | $-4.0M | $-11.0M | $-17.7M |
| Net Margin | — | — | — | — | — | — | -1,365.8% | — |
| EPS (Basic) | $-0.36 | $-0.32 | $-0.33 | $-0.33 | $-0.38 | $-0.19 | $-0.66 | $-1.20 |
| EPS (Diluted) | $-0.36 | $-0.32 | $-0.33 | $-0.33 | $-0.38 | $-0.19 | $-0.66 | $-1.20 |
| Shares Outstanding (Basic) | 42.1M | 36.5M | 34.5M | 30.0M | 24.4M | 22.5M | 17.4M | 16.1M |
| Shares Outstanding (Diluted) | 42.1M | 36.5M | 34.5M | 30.0M | 24.4M | 22.5M | 17.4M | 16.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |